Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cognitive functioning following discontinuation of antipsychotic medication. A naturalistic sub-group analysis from the OPUS II trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Assessing risk of neurodevelopmental disorders after birth with oxytocin: a systematic review and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Associations between P3a and P3b amplitudes and cognition in antipsychotic-naïve first-episode schizophrenia patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Validation of the Danish version of the brief negative symptom scale

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Poor response to dopaminergic antipsychotics constitutes a major challenge in the treatment of psychotic disorders and markers for non-response during first-episode are warranted. Previous studies have found increased levels of glutamate and γ-aminobutyric acid (GABA) in non-responding first-episode patients compared to responders, but it is unknown if non-responders can be identified using reference levels from healthy controls (HCs).

METHODS: Thirty-nine antipsychotic-naïve patients with first-episode psychosis and 36 matched HCs underwent repeated assessments with the Positive and Negative Syndrome Scale and 3T magnetic resonance spectroscopy. Glutamate scaled to total creatine (/Cr) was measured in the anterior cingulate cortex (ACC) and left thalamus, and levels of GABA/Cr were measured in ACC. After 6 weeks, we re-examined 32 patients on aripiprazole monotherapy and 35 HCs, and after 26 weeks we re-examined 30 patients on naturalistic antipsychotic treatment and 32 HCs. The Andreasen criteria defined non-response.

RESULTS: Before treatment, thalamic glutamate/Cr was higher in the whole group of patients but levels normalized after treatment. ACC levels of glutamate/Cr and GABA/Cr were lower at all assessments and unaffected by treatment. When compared with HCs, non-responders at week 6 (19 patients) and week 26 (16 patients) had higher baseline glutamate/Cr in the thalamus. Moreover, non-responders at 26 weeks had lower baseline GABA/Cr in ACC. Baseline levels in responders and HCs did not differ.

CONCLUSION: Glutamatergic and GABAergic abnormalities in antipsychotic-naïve patients appear driven by non-responders to antipsychotic treatment. If replicated, normative reference levels for glutamate and GABA may aid estimation of clinical prognosis in first-episode psychosis patients.

Original languageEnglish
JournalPsychological Medicine
Pages (from-to)1-12
Number of pages12
ISSN0033-2917
DOIs
Publication statusE-pub ahead of print - 16 Sep 2019

ID: 58198970